MEI Pharma Announces Private Placement for $100 Million Litecoin Treasury Strategy
2025-07-18 17:27:45
Main Idea
MEI Pharma announces a $100 million private investment at $3.42 per share, adopting Litecoin as part of its treasury strategy, with Charlie Lee joining its Board of Directors.
Key Points
1. MEI Pharma's $100 million private investment is backed by the Litecoin Foundation and crypto firms like MOZAYYX, ParaFi, Hivemind, and CoinFund.
2. Charlie Lee, creator of Litecoin, will join MEI’s Board of Directors as part of the deal.
3. MEI Pharma plans to use the funds to buy Litecoin, making it the company's primary treasury asset.
4. The deal is set to close by July 22, 2025, pending final approvals.
5. MEI Pharma’s stock surged 83% in pre-market trading following the announcement, with shares reaching a high of $9 before settling at $5.91, up 31% in 24 hours.
Description
The post MEI Pharma Announces Private Placement for $100 Million Litecoin Treasury Strategy appeared first on Coinpedia Fintech News MEI Pharma has announced a $100 million private investment at $3.42 per share, marking a bold step forward in its growth strategy. As part of the deal, Charlie Lee, creator of Litecoin, will join MEI’s Board of Directors, replacing Taheer Datoo. MEI has also appointed GSR as its digital asset and treasury advisor to help launch its new Litecoin Treasury Strategy, w...
Latest News
- Ripple (XRP) Surges 15% to $3.16, Breaking Key Resistance; Meanwhile, New Crypto Coin is Forecasted to Surge 11,200%2025-07-19 06:02:25
- Pump.fun Token Crashes Below ICO Price After $600M Hype Bust2025-07-19 05:50:41
- Crypto Regulation in Brazil 20252025-07-19 05:40:02
- Crypto Regulations in Thailand 20252025-07-19 05:39:14
- Jack Dorsey’s Block to Join the S&P 500 Index Next Week2025-07-18 22:29:02